Choose the fast lane
Leading technologies to accelerate manufacturing
of viral vector-based therapies
Turn Options into Opportunities
Choose the Fast Lane for Your Viral Vector-Based Therapies
We understand that speed is key in viral vector production. An optimized upstream workflow relies on high-performing, scalable solutions.
Make confident decisions and accelerate your viral vector production.
Accelerate Aav Manufacturing
Even for experienced biomanufacturers, moving to larger-scale production means rethinking each unit operation to meet volume and dosing needs. Download this whitepaper to explore key insights for high-performing, scalable viral vector manufacturing solutions.
Explore Integrated Solutions to Accelerate Your Viral Vector Manufacturing
Speed up your viral vector production
Explore viral vector upstream platforms for faster process optimization and improved consistency.
Explore scalable solutions
Discover high-performing options for scaling AAV and LV cell cultures with confidence.
Get on the List: Explore the Latest Advancements in Viral Vector Production
Stay ahead of new trends in biopharma and pharma manufacturing by subscribing to our newsletter. Discover the latest advancements, access recent webinars, and benefit from case studies and insights delivered by our technical experts.
Delve into our upstream viral vector platforms and comprehensive portfolio of cell culture solutions optimized for AAV and LV productivity, that accelerate your progress from process development to GMP manufacturing.
To continue reading please sign in or create an account.
Don't Have An Account?